Cargando…
Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol
Introduction: Evidence syntheses, often in the form of systematic reviews, are essential for clinical guideline development and informing changes to health policies. However, clinical guideline development groups (CGDG) are multidisciplinary, and participants such as policymakers, healthcare profess...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433911/ https://www.ncbi.nlm.nih.gov/pubmed/36071877 http://dx.doi.org/10.12688/hrbopenres.13325.2 |
_version_ | 1784780739278012416 |
---|---|
author | Sharp, Melissa K. Tyner, Barrie Awang Baki, Dayang Anis Binti Farrell, Cormac Devane, Declan Mahtani, Kamal R. Smith, Susan M. O'Neill, Michelle Ryan, Máirín Clyne, Barbara |
author_facet | Sharp, Melissa K. Tyner, Barrie Awang Baki, Dayang Anis Binti Farrell, Cormac Devane, Declan Mahtani, Kamal R. Smith, Susan M. O'Neill, Michelle Ryan, Máirín Clyne, Barbara |
author_sort | Sharp, Melissa K. |
collection | PubMed |
description | Introduction: Evidence syntheses, often in the form of systematic reviews, are essential for clinical guideline development and informing changes to health policies. However, clinical guideline development groups (CGDG) are multidisciplinary, and participants such as policymakers, healthcare professionals and patient representatives can face obstacles when trying to understand and use evidence synthesis findings. Summary formats to communicate the results of evidence syntheses have become increasingly common, but it is currently unclear which format is most effective for different stakeholders. This mixed-methods systematic review (MMSR) evaluates the effectiveness and acceptability of different evidence synthesis summary formats for CGDG members. Methods: This protocol follows guidance from the Joanna Briggs Institute on MMSRs and is reported according to the Preferred Reporting Items for Systematic Reviews (PRISMA)-P guideline. A comprehensive search of six databases will be performed with no language restrictions. Primary outcomes are those relating to the effectiveness and preferences for and attitudes towards the different summary formats. We will include qualitative research and randomised controlled trials. Two reviewers will perform title, abstract, and full-text screening. Independent double-extraction of study characteristics and critical appraisal items will be undertaken using a standardised form. We will use a convergent segregated approach to analyse quantitative and qualitative data separately; results will then be integrated. Discussion: The results of this systematic review will provide an overview of the effectiveness and acceptability of different summary formats for evidence synthesis findings. These findings can be helpful for those in or communicating to guideline development groups. The results can also inform the development and pilot-testing of summary formats for evidence summaries. |
format | Online Article Text |
id | pubmed-9433911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-94339112022-09-06 Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol Sharp, Melissa K. Tyner, Barrie Awang Baki, Dayang Anis Binti Farrell, Cormac Devane, Declan Mahtani, Kamal R. Smith, Susan M. O'Neill, Michelle Ryan, Máirín Clyne, Barbara HRB Open Res Study Protocol Introduction: Evidence syntheses, often in the form of systematic reviews, are essential for clinical guideline development and informing changes to health policies. However, clinical guideline development groups (CGDG) are multidisciplinary, and participants such as policymakers, healthcare professionals and patient representatives can face obstacles when trying to understand and use evidence synthesis findings. Summary formats to communicate the results of evidence syntheses have become increasingly common, but it is currently unclear which format is most effective for different stakeholders. This mixed-methods systematic review (MMSR) evaluates the effectiveness and acceptability of different evidence synthesis summary formats for CGDG members. Methods: This protocol follows guidance from the Joanna Briggs Institute on MMSRs and is reported according to the Preferred Reporting Items for Systematic Reviews (PRISMA)-P guideline. A comprehensive search of six databases will be performed with no language restrictions. Primary outcomes are those relating to the effectiveness and preferences for and attitudes towards the different summary formats. We will include qualitative research and randomised controlled trials. Two reviewers will perform title, abstract, and full-text screening. Independent double-extraction of study characteristics and critical appraisal items will be undertaken using a standardised form. We will use a convergent segregated approach to analyse quantitative and qualitative data separately; results will then be integrated. Discussion: The results of this systematic review will provide an overview of the effectiveness and acceptability of different summary formats for evidence synthesis findings. These findings can be helpful for those in or communicating to guideline development groups. The results can also inform the development and pilot-testing of summary formats for evidence summaries. F1000 Research Limited 2022-05-10 /pmc/articles/PMC9433911/ /pubmed/36071877 http://dx.doi.org/10.12688/hrbopenres.13325.2 Text en Copyright: © 2022 Sharp MK et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Sharp, Melissa K. Tyner, Barrie Awang Baki, Dayang Anis Binti Farrell, Cormac Devane, Declan Mahtani, Kamal R. Smith, Susan M. O'Neill, Michelle Ryan, Máirín Clyne, Barbara Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol |
title | Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol |
title_full | Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol |
title_fullStr | Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol |
title_full_unstemmed | Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol |
title_short | Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol |
title_sort | evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433911/ https://www.ncbi.nlm.nih.gov/pubmed/36071877 http://dx.doi.org/10.12688/hrbopenres.13325.2 |
work_keys_str_mv | AT sharpmelissak evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol AT tynerbarrie evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol AT awangbakidayanganisbinti evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol AT farrellcormac evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol AT devanedeclan evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol AT mahtanikamalr evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol AT smithsusanm evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol AT oneillmichelle evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol AT ryanmairin evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol AT clynebarbara evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol |